Evropska unija - slovenščina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Evropska unija - slovenščina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk vaccines gmbh - virus klopnega meningoencefalitisa, inaktivirani - suspenzija za injiciranje - virus klopnega meningoencefalitisa, inaktivirani 3 µg / 1 ml - cepivo proti klopnemu meningoencefalitisu, s celimi virusi, inaktivirano

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk vaccines gmbh - virus klopnega meningoencefalitisa, inaktivirani - suspenzija za injiciranje - virus klopnega meningoencefalitisa, inaktivirani 3 µg / 1 ml - cepivo proti klopnemu meningoencefalitisu, s celimi virusi, inaktivirano

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk vaccines gmbh - virus klopnega meningoencefalitisa, inaktivirani - suspenzija za injiciranje - virus klopnega meningoencefalitisa, inaktivirani 0,75 µg / 0,25 ml - cepivo proti klopnemu meningoencefalitisu, s celimi virusi, inaktivirano

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk vaccines gmbh - virus klopnega meningoencefalitisa, inaktivirani - suspenzija za injiciranje - virus klopnega meningoencefalitisa, inaktivirani 0,75 µg / 0,25 ml - cepivo proti klopnemu meningoencefalitisu, s celimi virusi, inaktivirano

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk d.o.o., ljubljana - virus mumpsa (sev jeryl lynn), živ, oslabljen; virus rdečk (sev wistar ra 27/3), živ, oslabljen; virus ošpic (sev schwarz), živ, oslabljen - prašek in vehikel za raztopino za injiciranje - virus mumpsa (sev jeryl lynn), živ, oslabljen 5011,87 ccid50 / 0,5 ml  virus rdečk (sev wistar ra 27/3), živ, oslabljen1000 ccid50 / 0,5 ml  virus ošpic (sev schwarz), živ, oslabljen1000 ccid50 / 0,5 ml; virus rdečk (sev wistar ra 27/3), živ, oslabljen 1000 ccid50 / 0,5 ml  virus ošpic (sev schwarz), živ, oslabljen1000 ccid50 / 0,5 ml; virus ošpic (sev schwarz), živ, oslabljen 1000 ccid50 / 0,5 ml - mešano cepivo proti ošpicam, mumpsu in rdečkam z oslabljenimi virusi

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk vaccines gmbh - virus klopnega meningoencefalitisa, inaktivirani - suspenzija za injiciranje - virus klopnega meningoencefalitisa, inaktivirani 0,75 µg / 0,25 ml - cepivo proti klopnemu meningoencefalitisu z inaktiviranimi virusi

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk vaccines gmbh - virus klopnega meningoencefalitisa, inaktivirani - suspenzija za injiciranje - virus klopnega meningoencefalitisa, inaktivirani 0,75 µg / 0,25 ml - cepivo proti klopnemu meningoencefalitisu z inaktiviranimi virusi

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pfizer luxembourg sarl - virus klopnega meningoencefalitisa, inaktivirani - suspenzija za injiciranje - virus klopnega meningoencefalitisa, inaktivirani 1,2 µg / 0,25 ml - cepivo proti klopnemu meningoencefalitisu, s celimi virusi, inaktivirano